Role of IHC markers in oral cancer
Not Applicable
- Conditions
- Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
- Registration Number
- CTRI/2024/02/063123
- Lead Sponsor
- Dr. Shilpi Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All biopsy cases from oral cavity diagnosed histopathologically as Squamous Cell Carcinoma during study period
Exclusion Criteria
Cancers of oral cavity other than Squamous cell carcinoma
Inadequate biopsy specimens
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate histomorphological findings of oral squamous cell carcinoma <br/ ><br> <br/ ><br>To determine E-Cadherine and Cyclin D1 immunohistochemical markers expression in oral squamous cell carcinoma <br/ ><br> <br/ ><br>To correlate immunohistochemical expression with histomorphological findings in these casesTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method To evaluate histomorphological findings of oral squamous cell carcinoma <br/ ><br> <br/ ><br>To determine E-Cadherine & Cyclin D1 immunohistochemical markers expression in oral squamous cell carcinoma <br/ ><br> <br/ ><br>To correlate immunohistochemical expression with histomorphological findings in these casesTimepoint: Monthly